Financière de Tubize S.A. Financière de Tubize S.A.

Financière de Tubize S.A.

TUB

Rankning i aktier #2204
Financière de Tubize SA, headquartered in Brussels, Belgium, operates as a... Financière de Tubize SA, headquartered in Brussels, Belgium, operates as a global biopharmaceutical firm, primarily through its investment in UCB. The company is dedicated to discovering and advancing innovative medicines and solutions focused on neurological and immunological disorders. Its current commercial offerings include Cimzia, an established treatment for a range of inflammatory conditions such as ankylosing spondylitis, axial spondyloarthritis, Crohn's disease, non-radiographic axial spondyloarthritis, plaque psoriasis, psoriatic arthritis, and rheumatoid arthritis. For partial-onset seizures in epilepsy, it provides Briviact, Vimpat, and Keppra, alongside Nayzilam, a nasal spray. Neupro addresses Parkinson's disease and restless legs syndrome. Additionally, the portfolio features Evenity, an injectable therapy for osteoporosis, and Bimzelx, used to manage moderate to severe plaque psoriasis. The company's development pipeline highlights several promising candidates: Staccato, aimed at stereotypical prolonged seizures; Bepranemab for Alzheimer's disease; and UCB0599 for Parkinson's disease. Other therapies under investigation include bimekizumab, which targets psoriasis, psoriatic arthritis, hidradenitis suppurativa, and axial spondyloarthritis; rozanolixizumab, for conditions like myasthenia gravis, immune thrombocytopenia, myelin oligodendrocyte glycoprotein antibody disease, and autoimmune encephalitis; and dapirolizumab pegol, intended for systemic lupus erythematosus.
Aktiekurs
$203.04
Senast synkroniserad: 2026-10-21
Marknadsvärde
$9.04B
Förändring (1 dag)
-7.47%
Förändring (1 år)
-22.97%
Land
BE
Handel Financière de Tubize S.A. (TUB)

Kategori

Healthcare
Historik för aktiesplit för Financière de Tubize S.A. (TUB)
Aktien Financière de Tubize S.A. (symbol: TUB) har genomgått totalt 3 aktiesplitar.
Den senaste spliten skedde den Jun 17, 2005.
En TUB-aktie köpt före May 24, 1988 motsvarar nu 211.6 TUB-aktier.
Lista över aktiesplitar
År Split Multipel Kumulativ multipel
2005-06-17 2:1 x2 x211.6
1999-11-26 100:1 x100 x105.8
1988-05-24 529:500 x1.058 x1.058
Aktiesplitar för liknande företag eller konkurrenter
Företag Antal aktiesplitar Kumulativ multipel Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 1 x2
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 0 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 1 x3
AU
Argenx SE Argenx SE
Argenx SE
ARGX.US
 0 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 0 -
CH